Compare Exelixis (EX9) vs. Competitors

1 Followers

Comparison Results

EX9

Exelixis

€46.93

€12.90B

17.89

48.02%

3 Buy

9 Hold

1 Sell

Hold

Incyte

$128.12

$23.37B

14.04

31.41%

11 Buy

10 Hold

0 Sell

Moderate Buy

Jazz Pharmaceuticals

$260.23

$15.30B

15.53

69.23%

18 Buy

1 Hold

0 Sell

Strong Buy

Summit Therapeutics

$14.23

$13.37B

-15.42

-19.41%

10 Buy

6 Hold

0 Sell

Moderate Buy

Zai Lab

$26.82

$2.84B

-13.94

-24.09%

3 Buy

0 Hold

0 Sell

Strong Buy

Genmab

$34.36

$20.25B

27.87

14.66%

9 Buy

1 Hold

0 Sell

Strong Buy

xxxxxxxxxxxxx

EX9 vs GMAB

xxxxxxxxxxxxx

Performance Comparison

DE:EX9

Exelixis

51.60

17.60

51.76%

INCY

Incyte

114.13

26.90

30.84%

JAZZ

Jazz Pharmaceuticals

236.04

98.46

71.57%

SMMT

Summit Therapeutics

17.27

-4.88

-22.03%

ZLAB

Zai Lab

25.62

-7.69

-23.09%

GMAB

Genmab

38.48

5.17

15.52%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >